Facile One Step Formation and Screening of Tumor Spheroids Using Droplet‐Microarray Platform. Issue 25 (6th May 2019)

• Record Type: Journal Article
• Authors: Popova, Anna A.; Tronser, Tina; Demir, Konstantin; Haitz, P.; Kuodyte, Karolina; Starkuviene, Vytaute; Wajda, Piotr; Levkin, Pavel A.
• Is Part Of: Small. Volume 15:Issue 25(2019)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-05-06
• Subjects: 3D cell culture -- droplet‐microarray -- high throughput compound screening -- microtumors -- tumor spheroids; Nanotechnology -- Periodicals; Nanoparticles -- Periodicals; Microtechnology -- Periodicals; 620.5
• DOI: 10.1002/smll.201901299
• Languages: English
• ISSNs: 1613-6810

Abstract

Abstract: Tumor spheroids or microtumors are important 3D in vitro tumor models that closely resemble a tumor's in vivo "microenvironment" compared to 2D cell culture. Microtumors are widely applied in the fields of fundamental cancer research, drug discovery, and precision medicine. In precision medicine tumor spheroids derived from patient tumor cells represent a promising system for drug sensitivity and resistance testing. Established and commonly used platforms for routine screenings of cell spheroids, based on microtiter plates of 96‐ and 384‐well formats, require relatively large numbers of cells and compounds, and often lead to the formation of multiple spheroids per well. In this study, an application of the Droplet Microarray platform, based on hydrophilic–superhydrophobic patterning, in combination with the method of hanging droplet, is demonstrated for the formation of highly miniaturized single‐spheroid‐microarrays. Formation of spheroids from several commonly used cancer cell lines in 100 nL droplets starting with as few as 150 cells per spheroid within 24–48 h is demonstrated. Established methodology carries a potential to be adopted for routine workflows of high‐throughput compound screening in 3D cancer spheroids or microtumors, which is crucial for the fields of fundamental cancer research, drug discovery, and precision medicine. Abstract : In the current study, the Droplet Microarray platform utilizing hydrophilic–superhydrophobic micropatterns is used in combination with the method of hanging droplet for the formation of single‐spheroid‐microarrays. Formation of spheroids from several commonly used cell lines and on‐chip drug treatment is demonstrated. Established methodology can be adopted for miniaturized high‐throughput compound screenings using physiologically relevant 3D spheroids.